There's a widely available, natural chemical that some doctors claim to significantly help cancer patients.  Sounds great, right?  The problem is you can't get it.  It hasn't been approved by the FDA yet.  It's not that the FDA says there is anything wrong with it, it's just that no pharmaceutical company has tried to get it approved.  It's not profitable for companies to make.  Therefore, why are they going to spend time and money producing something that won't make them rich?  Not to mention that the average cancer patient spends now about $80,000 a year on medication.  According to some doctors, this drug called DCA has already been shown to shrink tumors, inhibit cancer cell growth and help people where traditional cancer treatments have failed.  Who knows if it really works?  But if it's cheap, is anyone going to find out?  Think about if we cured diabetes today.  People would no longer have to buy test strips, blood sugar meters, insulin, etc.  It would be a huge financial blow to the medical industry.  It makes you wonder.  I'm not one for the conspiracy theories, but this got me thinking.   I found this article and I just felt like I had to share it with you.

Pharmacologist Omudhome Ogbru, an R&D director at a New Jersey-based pharmaceutical business, The Medicines Company, notes, "Drug companies are like other companies in that they manufacture products that must be sold for a profit in order for the company to survive and grow."

Only one in 10,000 compounds studied by researchers ends up as an approved drug, Ogbru explained in an op-ed at MedicineNet. To get to the approval phase, drugs must undergo seven to 10 years of testing at a total cost averaging $500 million — all of which can be for naught if the drug doesn't receive Food and Drug Administration approval. Even if it does, "only three out of every 20 approved drugs bring in sufficient revenue to cover their developmental costs."

"Profit is the incentive for the risk that the company takes," Ogbru wrote. "Without the promise of a reasonable profit, there is very little incentive for any company to develop new drugs."

Oh, and one more thing that makes my blood boil.  It's been approved in Canada.  What about us?